Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis

Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis

IntroductionHyperprogressive disease (HPD) is a paradoxically rapid disease progression during or shortly after antitumor treatment, especially immune checkpoint inhibitors (ICIs). Various diagnosis criteria of HPD cause heterogeneous incidence rates in different clinical research, and there is no c...

Full description

Bibliographic Details
Main Authors: Zijun Zhao, Jin Bian, Junwei Zhang, Ting Zhang, Xin Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
hyperprogressive disease
solid malignancy
immune checkpoint inhibitor
incidence and prognosis
systematic review and meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.843707/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.843707/full

Similar Items